Text size: AAA
Step into summer in the best shape of your life with these reports from Harvard Medical School.
Learn How

Start your exercise and fitness program and reap the benefits of being more fit, stronger and healthier!

Warmer weather is on the way and it's not too late to get in shape for the summer. These 3 reports can help you enjoy outdoor activities in the best shape of your life:

References for "Cytochrome P450 enzymes and psychiatric drugs"

FEB 2009

Next Article:

Did you know?

You can get instant online access to all of the articles from the February 2009 issue of Harvard Mental Health Letter for only $5.

Already a subscriber? Login for complete instant access.

If you want a button/link to remove the box (not sure if you do or not...), it would look like this: Cancel

Bondy B, et al. “Pharmacogenetics of Antipsychotics: Useful for the Clinician?” Current Opinion in Psychiatry (March 2007): Vol. 20, No. 2, pp. 126–30. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17278909

De Leon J, et al. “Clinical Guidelines for Psychiatrists for the Use of Pharmacogenetic Testing for CYP450 2D6 and CYP450 2C19,” Psychosomatics (Jan.–Feb. 2006): Vol. 47, No. 1, pp. 75–85. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16384813

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. “Recommendations from the EGAPP Working Group: Testing for Cytochrome P450 Polymorphisms in Adults with Nonpsychotic Depression Treated with Selective Serotonin Reuptake Inhibitors,” Genetics in Medicine (Dec. 2007): Vol. 9, No. 12, pp. 819–25. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18091431

Flockhart, DA. “Drug Interactions: Cytochrome P450 Drug Interaction Table, Version 4.0.” Accessed online Nov. 10, 2008, at http://medicine.iupui.edu/flockhart/table.htm.

Fujita K. “Food-Drug Interactions via Human Cytochrome P450 3A (CYP3A),” Drug Metabolism and Drug Interactions (April 2004): Vol. 20, No. 4, pp. 195–217. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15663291

Henry NL, et al. “Drug Interactions and Pharmacogenomics in the Treatment of Breast Cancer and Depression,” American Journal of Psychiatry (Oct. 2008): Vol. 165, No. 10, pp. 1251–5. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18829880

Ingelman-Sundberg M. “Pharmacogenetics of Cytochrome P450 and Its Applications in Drug Therapy: The Past, Present and Future,” Trends in Pharmacological Science (April 2004): Vol. 25, No. 4, pp. 193–200. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15063083

Matchar DB, et al. “Testing for Cytochrome P450 Polymorphisms in Adults with Nonpsychotic Depression Treated with Selective Serotonin Reuptake Inhibitors (SSRIs),” AHRQ Evidence Reports (Jan. 2007): AHRQ Publication No. 07-E002. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17764209

Perlis RH. “Cytochrome P450 Genotyping and Antidepressants,” BMJ (April 14, 2007): Vol. 334, No. 7597, pp. 759. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17431233

Smoller JW, et al., eds. Psychiatric Genetics: Applications in Clinical Practice (American Psychiatric Association, 2008).

Van der Weide J, et al. “The Influence of Cytochrome P450 Pharmacogenetics on Disposition of Common Antidepressant and Antipsychotic Medications,” Clinical Biochemistry Review (Feb. 2006): Vol. 27, No. 1, pp. 17–25. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16886044

Next Article: